This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Naegis Pharmaceuticals Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Julia Fonarev: Innovator in Leukotriene Synthesis Inhibitors
Introduction
Julia Fonarev is a notable inventor based in Richmond, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of leukotriene synthesis inhibitors. Her work focuses on providing specific compounds that can be used in treating inflammatory diseases and conditions.
Latest Patents
Julia holds 1 patent for her innovative work on leukotriene synthesis inhibitors. This patent includes specific compounds and pharmaceutical compositions that utilize these compounds for therapeutic purposes. The methods outlined in her patent aim to address various inflammatory diseases, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Julia has demonstrated a strong dedication to research and development in the pharmaceutical industry. She is currently associated with Naegis Pharmaceuticals Inc., where she continues to innovate and contribute to the field. Her expertise in leukotriene synthesis inhibitors positions her as a valuable asset in the fight against inflammatory conditions.
Collaborations
Julia has collaborated with esteemed colleagues, including David L. Burgoyne and Erin Debruin. These partnerships highlight her ability to work effectively within a team to achieve common goals in research and development.
Conclusion
Julia Fonarev's contributions to the field of pharmaceuticals, particularly through her patent on leukotriene synthesis inhibitors, underscore her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to improve the lives of those suffering from inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile